Peter Pickkers

Peter is an internist-intensivist and professor of Intensive Care Medicine. His research focuses on modulation of the innate immune response in translational models and patients, sepsis, and specific organ dysfunction, among which the kidney. So far, 30 Ph.D.’s completed their projects under his supervision. He has co-authored >500 articles and 30 book chapters and is a member of several steering committees of current sepsis trials. He is the principal investigator of the REVIVAL trial that investigates the effects of recombinant human alkaline phosphatase in patients with sepsis-induced acute kidney injury.